Literature DB >> 24161275

Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice.

F Lattanzio1, L Carboni2, D Carretta1, R Rimondini3, S Candeletti1, P Romualdi1.   

Abstract

The apolipoprotein E4 (apoE4) allele is consistently associated with increased risk for Alzheimer's disease (AD). We investigated the molecular mechanism of this susceptibility by analyzing the levels of genes involved in AD pathogenesis in transgenic mice expressing human apoE3 or apoE4 isoforms. mRNA and protein levels of Pin1, Sirtuin 1 (Sirt1), Presenilin 1 (PS1), and pro-Brain-derived Neurotrophic Factor (BDNF) were analyzed in brain regions affected by neuropathological changes in AD. Pin1 mRNA was significantly higher in the hippocampus of apoE4 mice than in apoE3 controls, whereas lower expression was detected in the entorhinal and parietal cortices. Reduced Pin1 levels may increase neurofibrillary degeneration and amyloidogenic processes, while compensatory mechanisms may take place in the hippocampus to balance spatial memory deficits. Sirt1 levels were significantly reduced in the frontal cortex of apoE4 mice. Sirt1 reduction may hinder its protective role against the formation of plaques and tangles and diminish its anti-inflammatory actions. Sirt1 decrease may also play a role in apoE4-associated memory impairments. Moreover, in apoE4 mice PS1 mRNA levels were lower in the frontal cortex. Lower PS1 expression may hamper γ-secretase function, thus affecting amyloid precursor protein processing. Pro-BDNF mRNA levels did not differ between apoE3 and apoE4 mice in any region analyzed. This study showed dysregulated expression of Pin1, Sirt1, and PS1 genes in different cerebral areas of apoE4 mice, suggesting that these changes may play a role in the mechanism of AD vulnerability.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AD; APP; Alzheimer’s disease; Aβ; BDNF; Brain-derived Neurotrophic Factor; DDCt; Delta–Delta Ct; EDTA; Forkhead box protein O; FoxO; LDL; NF-κB; NT; Nuclear factor κ B; PS1; Pin1; Presenilin 1; RT-qPCR; S.E.M.; Sirt1; Sirtuin 1; amyloid beta peptide; amyloid precursor protein; apoE; apoE TR mice; apolipoprotein E; apoliporpotein E; ethylenediaminetetraacetic acid; human apoE3- and apoE4-targeted replacement mice; low-density lipoprotein; neurofibrillary tangles; reverse transcription quantitative real-time polymerase chain reaction; standard error of the mean

Mesh:

Substances:

Year:  2013        PMID: 24161275     DOI: 10.1016/j.neuroscience.2013.10.017

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

Review 1.  Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease.

Authors:  Veena Theendakara; Clare A Peters-Libeu; Dale E Bredesen; Rammohan V Rao
Journal:  Mol Neurobiol       Date:  2017-09-06       Impact factor: 5.590

2.  Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.

Authors:  Jing-Hui Song; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-10-30       Impact factor: 5.590

3.  SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy.

Authors:  Xiaomin Yin; Yuanyuan Li; Xing Fan; Fang Huang; Yanyan Qiu; Chenhao Zhao; Zheng Zhou; Qun Gu; Liye Xia; Junze Bao; Xiaochuan Wang; Fei Liu; Wei Qian
Journal:  Mol Psychiatry       Date:  2022-07-25       Impact factor: 13.437

4.  Time-course miRNA alterations and SIRT1 inhibition triggered by adolescent lead exposure in mice.

Authors:  Rundong Liu; Yawei Wang; Lin Bai; Ruike Wang; Yingying Wu; Mengchen Liu; Qiong Li; Yue Ba; Huizhen Zhang; Guoyu Zhou; Xuemin Cheng; Hui Huang
Journal:  Toxicol Res (Camb)       Date:  2021-06-07       Impact factor: 2.680

Review 5.  A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease.

Authors:  Huiyi Chen; Feng Chen; Ying Jiang; Lu Zhang; Guizhen Hu; Furong Sun; Miaoping Zhang; Yao Ji; Yanting Chen; Gang Che; Xu Zhou; Yu Zhang
Journal:  Front Aging Neurosci       Date:  2022-05-20       Impact factor: 5.702

6.  C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer's disease.

Authors:  Yiyuan Xia; Zhi-Hao Wang; Jichun Zhang; Xia Liu; Shan Ping Yu; Karen X Ye; Jian-Zhi Wang; Keqiang Ye; Xiao-Chuan Wang
Journal:  Mol Psychiatry       Date:  2020-12-18       Impact factor: 15.992

7.  Application of Targeted Mass Spectrometry for the Quantification of Sirtuins in the Central Nervous System.

Authors:  T Jayasena; A Poljak; N Braidy; L Zhong; B Rowlands; J Muenchhoff; R Grant; G Smythe; C Teo; M Raftery; P Sachdev
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

8.  A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model.

Authors:  Jesus Campagna; Patricia Spilman; Barbara Jagodzinska; Dongsheng Bai; Asa Hatami; Chunni Zhu; Tina Bilousova; Michael Jun; Chris Jean Elias; Johnny Pham; Gregory Cole; Mary Jo LaDu; Michael E Jung; Dale E Bredesen; Varghese John
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

9.  ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans.

Authors:  Edward F Griffin; Samuel E Scopel; Cayman A Stephen; Adam C Holzhauer; Madeline A Vaji; Ryan A Tuckey; Laura A Berkowitz; Kim A Caldwell; Guy A Caldwell
Journal:  Dis Model Mech       Date:  2019-02-15       Impact factor: 5.758

10.  Presence of the apolipoprotein E-ε4 allele is associated with an increased risk of sepsis progression.

Authors:  Yiming Shao; Tian Zhao; Wenying Zhang; Junbing He; Furong Lu; Yujie Cai; Zhipeng Lai; Ning Wei; Chunmei Liang; Lizhen Liu; Yuan Hong; Xiaohong Cheng; Jia Li; Pei Tang; Weihao Fan; Mingqian Ou; Jingqi Yang; Yansong Liu; Lili Cui
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.